Login / Signup

Hyaluronic acid prodrug micelles for tumour therapy.

Jiao SunLingyu HanShubiao Zhang
Published in: Journal of drug targeting (2021)
Hyaluronic acid (HA), an important component of the extracellular matrix, has high water solubility and biocompatibility, and good application prospects in biomedicine. Especially in tumour treatment, prodrug polymer micelles prepared from HA and chemotherapeutics can increase water solubility, prolong drug release time, improve organ distribution and therapeutic effects, and show good tumour targeting and biocompatibility. Therefore, this study introduces strategies for using HA to prepare prodrug polymer micelles and discusses recent research on HA prodrug micelles for antitumor applications.
Keyphrases
  • drug release
  • hyaluronic acid
  • drug delivery
  • extracellular matrix
  • cancer therapy
  • stem cells
  • combination therapy
  • mesenchymal stem cells
  • replacement therapy